Figure 8.
Antitumor effects of LHD/miR-375 in Akt/Ras-induced HCC mice.
Notes: (A) Overall diagram of study design. (B) Liver morphology and Ki67 analysis of mice treated with saline, free DOX, LH/miR-375, LHD, or LHD/miR-375 (equivalent of 6 mg/kg DOX or 4 nmol/kg miR-375) for 2 weeks. (C) The average liver weights for each group (n=3). (D) Body weight changes (n=3) during experimental period since the Akt/Ras injections. The arrow refers to the first time of drug administration. (E) Hematoxylin and eosin staining of HCC mouse organs after treatment with drugs. Mouse organs or tumor tissues were collected after killing the mice at the end of experiment. Magnification: 200×. *P<0.05; ***P<0.001.
Abbreviations: DOX, doxorubicin hydrochloride; HCC, hepatocellular carcinoma; LH, lipid-coated hollow mesoporous silica nanoparticles; LHD, lipid-coated hollow mesoporous silica nanoparticles containing doxorubicin hydrochloride.